查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598508

經皮電神經刺激市場：按手術技術、產品和最終用戶分類 - 全球預測 2025-2030

Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), Product (Desktop, Portable), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年經皮皮電神經刺激市值為3.3669億美元，預計2024年將達到3.4882億美元，複合年成長率為3.69%，2030年將達到4.3408億美元，預計將達到1000萬美元。

經皮神經電刺激 (TENS) 是治療方法。 TENS 的應用範圍包括各種疼痛管理應用，例如慢性下背痛、關節炎和纖維肌痛，最終用途包括醫療機構、診所和家庭護理機構。由於人們對鴉片類藥物危機的認知不斷提高以及對替代療法的需求增加，人們對非侵入性、無藥物的止痛解決方案的日益偏好也支持了對 TENS 的需求。影響 TENS 市場成長的關鍵因素包括技術進步，例如提高移動性和便利性的無線 TENS 設備、更容易患疼痛相關疾病的全球人口老齡化以及慢性疼痛患者數量的增加。最近的技術創新，例如與行動應用程式整合的穿戴式 TENS 設備，用於個人化治療，帶來了巨大的成長機會。此外，擴大監管核准和增加研發投資以提高療效和病患治療效果也凸顯了市場參與者的有利領域。

主要市場統計
基準年[2023] 33669萬美元
預測年份 [2024] 34882萬美元
預測年份 [2030] 43408萬美元
複合年成長率（%） 3.69%

儘管如此，市場面臨可能阻礙成長的挑戰，包括嚴格的監管障礙和報銷問題。對 TENS 在嚴重疼痛管理方面的有效性的懷疑以及來自藥物和其他電療設備等替代療法的競爭也構成了障礙。為了利用市場機會，公司應該投資穿戴式裝置的開發和人工智慧主導的分析，以實現更個人化的疼痛管理。將 TENS 與其他治療方法結合以改善疼痛緩解效果的研究可以提供競爭優勢。此外，旨在解決對臨床效率的懷疑的教育宣傳活動和遊說有利的報銷政策可能會增加市場採用率。總體而言，只要透過策略舉措和技術進步克服現有挑戰，TENS 市場仍然充滿活力，並且具有巨大的創新潛力。

市場動態：快速發展的經皮電神經刺激市場的關鍵市場洞察

供需的動態交互作用正在改變經經皮神經電刺激市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 物理治療師越來越青睞肌肉刺激器
    • 運動醫學中越來越重視疼痛管理治療
    • 人群中肌肉骨骼疾病的盛行率上升
  • 市場限制因素
    • 神經刺激治療的成本增加
  • 市場機會
    • 醫療保健領域使用的機器不斷進步和現代化
    • 活性化醫療保健領域的研發活動
  • 市場挑戰
    • 缺乏熟練且訓練有素的醫生

波特五力：駕馭經皮電神經刺激市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對經皮電神經刺激市場的外在影響

外部宏觀環境因素在塑造經皮電神經刺激市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解經皮神經電刺激市場的競爭格局

經皮電神經刺激市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣經皮電神經刺激市場供應商的績效評估

FPNV 定位矩陣是評估經皮電神經刺激市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了經皮電神經刺激市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對經皮電神經刺激市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 肌肉刺激器在物理治療師中越來越受歡迎
      • 疼痛管理治療在運動醫學的重要性日益增加
      • 該國肌肉骨骼疾病的盛行率正在增加。
    • 抑制因素
      • 神經刺激治療的成本增加
    • 機會
      • 醫療保健領域所用機器的技術進步與現代化進步
      • 醫療保健領域的研發活動增加
    • 任務
      • 缺乏熟練且訓練有素的醫生
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

經皮外科手術經皮電神經刺激市場

  • 直接神經修復
  • 神經移植
  • 幹細胞療法

第7章經皮電神經刺激市場：依產品

  • 桌面
  • 可攜式的

第8章經皮電神經刺激市場：依最終用戶分類

  • 診所
  • 醫院

第9章美洲經皮電神經刺激市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太經經皮電神經刺激市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲經皮神經電刺激市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioMedical Life Systems
  • Bioness, Inc.
  • Boston Scientific Corporation
  • Chirag Electronics Private Limited, Smra
  • Cochlear Ltd
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO LLC.
  • ElectroCore, Inc.
  • EMS Physio Ltd
  • Medtronic plc
  • NeuroMetrix, Inc.
  • NeuroPace Inc
  • Nevro Corp
  • OMRON Corporation
  • R-slimming Medical Systems
  • Uroplasty, Inc.
  • Zynex Medical
Product Code: MRR-0355054AC4CA

The Transcutaneous Electrical Nerve Stimulation Market was valued at USD 336.69 million in 2023, expected to reach USD 348.82 million in 2024, and is projected to grow at a CAGR of 3.69%, to USD 434.08 million by 2030.

Transcutaneous Electrical Nerve Stimulation (TENS) is a therapeutic modality that utilizes low-voltage electrical current to relieve pain. The scope of TENS includes its application in various pain management contexts such as chronic back pain, arthritis, and fibromyalgia, and its end-use spans across healthcare facilities, clinics, and homecare settings. The necessity of TENS is underscored by the growing preference for non-invasive and drug-free pain relief solutions, driven by increasing awareness of the opioid crisis and the demand for alternative therapies. Key factors influencing the growth of the TENS market include advancements in technology, such as wireless TENS units, which offer enhanced mobility and convenience; an aging global population predisposed to pain-related ailments; and an expanding base of chronic pain sufferers. Recent innovations, such as wearable TENS devices integrated with mobile apps for personalized treatment, present significant growth opportunities. Moreover, expanding regulatory approvals and increased investment in R&D to enhance efficacy and patient outcomes highlight lucrative areas for market players.

KEY MARKET STATISTICS
Base Year [2023] USD 336.69 million
Estimated Year [2024] USD 348.82 million
Forecast Year [2030] USD 434.08 million
CAGR (%) 3.69%

Nevertheless, the market faces challenges such as stringent regulatory hurdles and reimbursement issues that may hinder growth. Skepticism regarding the efficacy of TENS in managing severe pain and competition from alternative treatments like pharmaceuticals and other electrotherapy devices also pose hurdles. To capitalize on market opportunities, businesses should invest in developing wearable devices and AI-driven analytics for more personalized pain management. Research into combining TENS with other therapies to enhance pain relief outcomes could present competitive advantages. Moreover, educational campaigns to address clinical efficiency skepticism and lobbying for favorable reimbursement policies can expand market adoption. Overall, the TENS market remains dynamic with significant potential for innovation, contingent on overcoming existing challenges through strategic initiatives and technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transcutaneous Electrical Nerve Stimulation Market

The Transcutaneous Electrical Nerve Stimulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising popularity of muscle stimulators among physiotherapists
    • Increasing emphasis on pain management therapies in sports medicine
    • Rising prevalence of musculoskeletal disorders among citizens
  • Market Restraints
    • Increased cost of nerve stimulation therapy
  • Market Opportunities
    • Rising technological advancements and modernization in the machinery used in healthcare sector
    • Rising research and development activities in the healthcare sector
  • Market Challenges
    • Lack of skilled or trained physicians

Porter's Five Forces: A Strategic Tool for Navigating the Transcutaneous Electrical Nerve Stimulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transcutaneous Electrical Nerve Stimulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transcutaneous Electrical Nerve Stimulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transcutaneous Electrical Nerve Stimulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transcutaneous Electrical Nerve Stimulation Market

A detailed market share analysis in the Transcutaneous Electrical Nerve Stimulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transcutaneous Electrical Nerve Stimulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transcutaneous Electrical Nerve Stimulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transcutaneous Electrical Nerve Stimulation Market

A strategic analysis of the Transcutaneous Electrical Nerve Stimulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transcutaneous Electrical Nerve Stimulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMedical Life Systems, Bioness, Inc., Boston Scientific Corporation, Chirag Electronics Private Limited, S.m.r.a, Cochlear Ltd, Cogentix Medical, Inc., Cyberonics, Inc., DJO LLC., ElectroCore, Inc., EMS Physio Ltd, Medtronic plc, NeuroMetrix, Inc., NeuroPace Inc, Nevro Corp, OMRON Corporation, R-slimming Medical Systems, Uroplasty, Inc., and Zynex Medical.

Market Segmentation & Coverage

This research report categorizes the Transcutaneous Electrical Nerve Stimulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Surgery Procedures, market is studied across Direct Nerve Repair, Nerve Grafting, and Stem Cell Therapy.
  • Based on Product, market is studied across Desktop and Portable.
  • Based on End User, market is studied across Clinics and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising popularity of muscle stimulators among physiotherapists
      • 5.1.1.2. Increasing emphasis on pain management therapies in sports medicine
      • 5.1.1.3. Rising prevalence of musculoskeletal disorders among citizens
    • 5.1.2. Restraints
      • 5.1.2.1. Increased cost of nerve stimulation therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancements and modernization in the machinery used in healthcare sector
      • 5.1.3.2. Rising research and development activities in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled or trained physicians
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transcutaneous Electrical Nerve Stimulation Market, by Surgery Procedures

  • 6.1. Introduction
  • 6.2. Direct Nerve Repair
  • 6.3. Nerve Grafting
  • 6.4. Stem Cell Therapy

7. Transcutaneous Electrical Nerve Stimulation Market, by Product

  • 7.1. Introduction
  • 7.2. Desktop
  • 7.3. Portable

8. Transcutaneous Electrical Nerve Stimulation Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospital

9. Americas Transcutaneous Electrical Nerve Stimulation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. BioMedical Life Systems
  • 4. Bioness, Inc.
  • 5. Boston Scientific Corporation
  • 6. Chirag Electronics Private Limited, S.m.r.a
  • 7. Cochlear Ltd
  • 8. Cogentix Medical, Inc.
  • 9. Cyberonics, Inc.
  • 10. DJO LLC.
  • 11. ElectroCore, Inc.
  • 12. EMS Physio Ltd
  • 13. Medtronic plc
  • 14. NeuroMetrix, Inc.
  • 15. NeuroPace Inc
  • 16. Nevro Corp
  • 17. OMRON Corporation
  • 18. R-slimming Medical Systems
  • 19. Uroplasty, Inc.
  • 20. Zynex Medical

LIST OF FIGURES

  • FIGURE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023